Catalent
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Catalent and buy or sell other stocks, ETFs, and their options commission-free!About CTLT
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services.
CEOAlessandro Maselli
CEOAlessandro Maselli
Employees—
Employees—
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1933
Founded1933
Employees—
Employees—
CTLT Key Statistics
Market cap11.52B
Market cap11.52B
Price-Earnings ratio-27.97
Price-Earnings ratio-27.97
Dividend yield—
Dividend yield—
Average volume4.49M
Average volume4.49M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$63.50
52 Week high$63.50
52 Week low$42.11
52 Week low$42.11
Stock Snapshot
The current Catalent(CTLT) stock price is $63.48, with a market capitalization of 11.52B. The stock trades at a price-to-earnings (P/E) ratio of -27.97.
Catalent(CTLT) stock opened on 2025-12-23 at —. The price climbed to — and dipped to —.
Catalent(CTLT) shares are trading with a volume of 0, against a daily average of 4.49M.
In the last year, Catalent(CTLT) shares hit a 52-week high of $63.50 and a 52-week low of $42.11.
In the last year, Catalent(CTLT) shares hit a 52-week high of $63.50 and a 52-week low of $42.11.
People also own
Based on the portfolios of people who own CTLT. This list is generated using Robinhood data, and it’s not a recommendation.